|
Market Closed -
Nasdaq
21:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.070 USD | +1.47% |
|
-2.36% | -40.17% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GRCE | Delayed | |
CBOE
| GRCE | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.16 | 3.14 | 3.18 |
| Spread/Res. | -4.17% | -34.08% | -34.91% |
| Spread/Supp. | +1.47% | +1.47% | +16.95% |
| Support | 2.04 | 2.04 | 1.77 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GRCE Stock
- Charts Grace Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
